Trending : Blood Pressure Monitoring Devices & Accessories Market Companies to Garner Bursting Revenues with Top Growing Companies During 2019 - 2027Transparency Market Research (TMR) has published a new report titled, ‘Plasma Protein Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the Plasma Protein Therapeutics Market was valued at US$ 22,413.9 Mn in 2018 and is projected to expand at a CAGR of 7.0% from 2019 to 2027.
Plasma-derived therapies and their recombinant analogs, collectively referred to as plasma protein therapies, are unique, biologic medicines, versus synthetic or chemical medicines, because production begins with plasma, a biologic starting material.
Stringent Regulations and Reimbursement Issues, diagnosis rate, public awareness and high price of the biological are the major market barrier. High demand in plasma protein therapeutic proteins and medicinal use in new indications, penetration of existing indications, better access to medicines in emerging markets, aging population, and new plasma-derived therapies are likely to drive the market.
North America is poised to cover a high share in 2018, while Asia Pacific is poised to grow at a highest CAGR in the forecast. The growth of plasma derived market in North America is mainly due to increasing IVIG sales during the forecast period. There is a growing demand of Albumin in Asia Pacific market, followed by Latin America.
Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) : https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10424
Growing Investment in Innovation, Rising Demand for Immunoglobulin (IG) and Rising Indications and Therapeutic use of Plasma Derived Protein Therapeutics to Drive Market
The plasma protein industry has been investing in research and development of new plasma proteins therapies (e.g.: Ceruloplasmin, IgA, Plasmin) leading to innovative treatments for the benefits of patients. In March 2016, Grifols announced that it will invest US$ 360 Mn to expand its production capabilities for plasma-derived therapies. The investment will increase the plasma fractionation capacity and purification of several proteins. Thus this factors drive the growing investment in innovation.
Plasma-derived IG is used for a wide range of autoimmune and inflammatory diseases. Increased recognition and treatment of immune deficiencies in developing world have added to the global demand for IG. However, increased use of high dose therapy, particularly in autoimmune neurologic diseases is the major reason for the continued strong growth in demand for IG products. Thus this factors drive the demand for immunoglobulin.
Plasma protein therapies are used in the treatment of rare diseases. The therapies include: Immunoglobulin’s used to treat a number of diseases in individuals with immune deficiencies and autoimmune diseases, Clotting-factor therapies used for individuals with hemophilia A and B and other bleeding disorders, Albumin, which is used in acute settings to treat individuals with shock, trauma, burns and other conditions. Thus this factors drive the plasma protein therapeutics and their uses.
REQUEST FOR COVID19 IMPACT ANALYSIS – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=10424
Immunoglobulin Segment to Dominate Market
Based on product type, the Plasma Protein Therapeutics Market has been divided into Immunoglobulin, Albumin, Coagulation Factor, C1-esterase inhibitors and others. The Immunoglobulins are plasma derived molecules, which account for a major share of the plasma derived protein products market. Intravenous immunoglobulin (IVIG) is a major product derived from large pools of human plasma containing antibodies against a broad spectrum of bacterial and viral agents. High global demand for IVIG is due to increased usage in primary immunodeficiency and neurological applications. The Immunoglobulins segment dominated the Plasma Protein Therapeutics Market in 2018 and the trend is projected to continue during the forecast period.
Hereditary Angioedema to be Highly Lucrative Segment
In terms of applications, the Plasma Protein Therapeutics Market has been classified into Hemophilia, “Primary Immunodeficiency Disorder (PID)”, “Idiopathic Thrombocytopenic, Purpura”, Secondary Immunodeficiency, Hereditary Angioedema, Other applications.
Hereditary angioedema (HAE) is a rare disorder caused by C1 esterase inhibitor deficiency. It accounts for only 2% of clinical angioedema cases. In type 1 and type 2 cases of hereditary angioedema, the former is the 85% of the cases. The worldwide incidence of HAE is approximately 1 in 30,000 to 50,000 persons. Growing awareness and treatment rate is expected to drive the segment.
North America to Dominate Global Market
In terms of region, the Plasma Protein Therapeutics Market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the Plasma Protein Therapeutics Market in 2018, followed by Europe.
The immunoglobulin segment accounted for the largest share of the market in North America in 2015. The C1 esterase inhibitors segment is poised to expand at a high CAGR, followed by the albumin segment during the forecast period. The coagulation factor (VIII and IX) segment would decline at a CAGR of 7.8% due to increasing trend in usage of recombinant proteins and rising FDA approvals.
Albumex and Buminate are the key brands in North America. Increasing therapeutic usage in new indications such as cirrhosis, acute liver failure, and amyotrophic lateral sclerosis is likely to drive the market. Moreover, the FDA approval for capacity expansion is expected to propel the market. For instance, CSL Ltd. received FDA approval for Albumin capacity expansion in Kankakee, U.S. that would automatically increase production, thus boosting market growth in the U.S.
Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
The Plasma Protein Therapeutics Market is fragmented in terms of number of players. Key players in the global market include Baxter International, Biotest, CSL Behring, GRIFOLS, S.A., Kedrion, Octapharma USA, Inc., Shire Plc., China Biologics and among others
The Plasma Protein Therapeutics Market has been segmented as follows:
Global Plasma Protein Therapeutics Market , by Product Type
Global Plasma Protein Therapeutics Market , by Application
Global Plasma Protein Therapeutics Market , by Region
Rest of Europe
Australia & New Zealand
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
More Trending Reports by Transparency Market Research – 1. https://www.prnewswire.com/news-releases/global-hemorrhoid-treatment-devices-market-to-grow-at-over-4-6-cagr-from-2018-to-2026-transparency-market-research-301001722.html
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Trending : Blood Pressure Monitoring Devices & Accessories Market Companies to Garner Bursting Revenues with Top Growing Companies During 2019 - 2027 here
News-ID: 2109868 • Views: 167
More Releases from Transparency Market Research
High Nutritional Content Fuelling Demand For Yogurt Market
Rising awareness about the benefits of yogurt over curd is propelling the demand for yogurt among consumers Yogurt has lower sugar and fat content, making it preferable for health conscious customers. Besides, manufacturers are boosting the nutrition value by adding minerals, vitamins, and fiber in the product. For example, Arla foods, a food manufacturing company, has recently introduced fiber-rich yogurt. The yogurt has high protein content, adequate amount of
Increasing Inclination Towards Healthy Lifestyle To Propel Protein Supplements M …
According to a new report by Transparency Market Research (TMR), a leading market intelligence firm, the global protein supplements market is witnessing a tremendous rise in its valuation, thanks to the increased focus of consumers towards acquiring a healthy lifestyle. With the presence of a large number of players, such as GlaxoSmithKline Plc, Amway Corp., ABH Pharma Inc., Vitacost.com Inc., and Nu Skin Enterprises Inc., the competitive landscape in the
Ginger Market is expected to reach a valuation of US$4.18 bn by the end of 2022
The global reach and acceptance for spices, especially for ginger have been increasing in recent years, presenting promising growth opportunities for large-scale manufacturers and processors of the spice that also promises vast health benefits, observes Transparency Market Research in a recent report. The global ginger market has multiple players, owing to which the vendor landscape is fragmented and is competitive in nature. Read report Overview- https://www.transparencymarketresearch.com/ginger-market.html The dominant players in the global
Feather Meal Market: Import-Export, Industry Chain Structure and Development Opp …
A recent study published by Transparency Market Research on the feather meal market includes global industry analysis and opportunity assessment for 2020-2030. Revenue generated from the global feather meal market was valued at US$ 359.5 Mn in 2020, which is estimated to rise at a CAGR of 8.6%, to reach ~US$ 820 Mn by 2030. Obtain Report Details @ https://www.transparencymarketresearch.com/feather-meal-market.html global feather meal market Nutritive Value of Feather Meal to Influence Feather
More Releases for Plasma
Bovine Blood Plasma Derivatives
Increasing use of bovine blood plasma derivatives in biopharmaceutical companies for cell culture technique, biotechnology, and research and development is expected to drive the market growth. For Instance, in November 2018, Wageningen University initiated the preclinical trial for Bovine plasma protein powder to assess the protein digestion kinetics and protection of the epithelial barriers including other markers for identification of gastrointestinal health, metabolic health, and vascular health, and satiating properties.
Platelet, Plasma Market
Platelet, Plasma Market is estimated to surpass $ 6.3 Billion markets in 2019 and reach USD 14.56 Billion by 2024, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period 2016-2024 globally. For More Information Visit https://www.maximizemarketresearch.com/market-report/platelet-plasma-market/11293/ A rising incidence of haemophilia, thrombocytopenia, autoimmune diseases as well as other infectious and rare disease will serve to be a key driver for the platelet and plasma market growth. According
Global Blood Plasma Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis Global Blood Plasma Market. The report analyses the Blood Plasma Market By Type (Immunoglobulins- IV+SC, Albumin, Factor VIII- Plasma Derived, and Others), By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S, Canada, Germany, France, Italy, China, Japan, India, Australia,
Cold Plasma Technology Market Size
This report focuses on the global Cold Plasma Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cold Plasma Technology development in United States, Europe and China. In 2017, the global Cold Plasma Technology market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. Download FREE Sample of
Plasma Light Market: Pure Plasma Lighting, Lightahead, CozyCabin, RioRand, Cryst …
MarketResearchReports.Biz adds “Global Plasma Light Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Plasma Light market and the growth estimates for the forecasted period. This report studies the global Plasma Light market status and forecast, categorizes the global Plasma Light market size (value & volume) by key players, type, application, and region. This report focuses on the top
Plasma Equipment Market Trend to 2025 Profiling Plasma Air, Plasma etching techn …
The Plasma Equipment Market Research Report Forecast 2018-2025 is a valuable source of insightful data for business strategists. It provides the Plasma Equipment industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. In this report, the global Plasma Equipment market value is provided for 2017 in million-dollar terms